Company / Current Liabilities per Share
Syndax Pharmaceuticals Inc Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.40
FY2025
5-year range
$0.43 / $1.40
FY2021-FY2025
Trend
+14.8%
vs FY2024
Sector context
#95 of 210
Health Care
What the data says
At $1.40, Syndax Pharmaceuticals Inc's current liabilities per share ranks #116 of 210 in the Health Care sector. Current Liabilities per Share has increased for 4 consecutive years, from $0.43 in FY2021 to $1.40 in FY2025.
Based on SEC 10-K filings.
1.40 in FY2025 with a 5-year CAGR of +15.1%.
Increased from $0.85 to $1.40 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +38.4%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#116 of 210 in Health CareTop 55% of 210This company $1.40 Sector average $23.79
▼
-94.1% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 14.8% year-over-year.
- Ranks #95 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.40 | +14.8% |
| FY2024 | $1.22 | +43.1% |
| FY2023 | $0.85 | +61.4% |
| FY2022 | $0.53 | +22.4% |
| FY2021 | $0.43 | -37.9% |
| FY2020 | $0.70 | -6.0% |
| FY2019 | $0.74 | +12.0% |
| FY2018 | $0.66 | -23.9% |
| FY2017 | $0.87 | -99.3% |
| FY2016 | $121.32 | +71.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026